Overview A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845 Status: Recruiting Trial end date: 2021-12-25 Target enrollment: Participant gender: Summary A clinical trial to evaluate the pharmacokinetic profiles and safety of CKD-845. Phase: Phase 1 Details Lead Sponsor: Chong Kun Dang Pharmaceutical